ArticleScience translational medicine2021

Hexose-6-phosphate dehydrogenase blockade reverses prostate cancer drug resistance in xenograft models by glucocorticoid inactivation.

Jianneng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.